Karin E Peterson Selected Research

Karin E Peterson Research Topics

Disease

26	Infections 01/2022 - 03/2002
9	Virus Diseases (Viral Diseases) 08/2021 - 06/2004
5	Neuroinflammatory Diseases 04/2016 - 11/2008
5	Retroviridae Infections (Infection, Retrovirus) 12/2015 - 03/2002
2	Encephalitis (Encephalitis, Rasmussen) 11/2021 - 11/2021
2	Viral Encephalitis 11/2021 - 11/2021
2	Bacterial Infections (Bacterial Infection) 01/2020 - 10/2015
2	Gliosis 04/2016 - 01/2009
2	Alzheimer Disease (Alzheimer's Disease) 04/2016 - 10/2006
2	Central Nervous System Diseases (CNS Diseases) 04/2016 - 06/2004
2	Bunyaviridae Infections 01/2015 - 04/2013
1	Zika Virus Infection 11/2021
1	Neuroblastoma 11/2021
1	Hepatitis C 01/2020
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2020
1	Scrapie 04/2016
1	Parkinson Disease (Parkinson's Disease) 04/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2016
1	Frontotemporal Dementia (Semantic Dementia) 04/2016
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 04/2016
1	Pain (Aches) 05/2014
1	Globoid Cell Leukodystrophy (Krabbe Disease) 02/2014
1	Demyelinating Diseases (Demyelinating Disease) 02/2014
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 02/2014
1	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2013
1	Necrosis 02/2013
1	Multiple Sclerosis 10/2006
1	Dementia (Dementias) 10/2006
1	Nervous System Diseases (Neurological Disorders) 08/2006

Drug/Important Bio-Agent (IBA)

8	CytokinesIBA 01/2020 - 10/2006
5	ChemokinesIBA 01/2009 - 06/2004
4	Messenger RNA (mRNA)IBA 01/2022 - 11/2010
3	PrionsIBA 01/2022 - 11/2009
3	Proteins (Proteins, Gene)FDA Link 04/2016 - 04/2013
3	Toll-Like Receptor 7IBA 02/2013 - 11/2008
2	rottlerinIBA 11/2021 - 11/2021
2	Antiviral Agents (Antivirals)IBA 11/2021 - 04/2013
2	Neuropeptide YIBA 12/2015 - 11/2010
2	AntibodiesIBA 10/2015 - 08/2004
2	LigandsIBA 08/2006 - 06/2004
2	VaccinesIBA 08/2004 - 08/2002
1	PolyphenolsIBA 11/2021
1	Pharmaceutical PreparationsIBA 11/2021
1	Indicators and Reagents (Reagents)IBA 11/2021
1	Salivary Proteins and PeptidesIBA 08/2021
1	AntigensIBA 01/2020
1	Pattern Recognition ReceptorsIBA 01/2020
1	InterferonsIBA 11/2019
1	IronIBA 01/2017
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017
1	Peptide Hydrolases (Proteases)FDA Link 04/2016
1	Prion ProteinsIBA 04/2016
1	GlucocorticoidsIBA 01/2016
1	Interferon-alpha (Interferon Alfa)IBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2015
1	Interferon Type IIBA 10/2014
1	CationsIBA 05/2014
1	Pathogen-Associated Molecular Pattern MoleculesIBA 04/2014
1	GalactosylceramidaseIBA 02/2014
1	Psychosine (Galactosylsphingosine)IBA 02/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2014
1	Complement System Proteins (Complement)IBA 12/2013
1	RNA Helicases (RNA Helicase)IBA 04/2013
1	OligodeoxyribonucleotidesIBA 08/2011
1	GuanosineIBA 08/2011
1	Phosphates (Orthophosphate)IBA 08/2011
1	Imiquimod (Aldara)FDA LinkGeneric 08/2011
1	Nucleic AcidsIBA 08/2011
1	CytosineIBA 08/2011
1	CPG-oligonucleotideIBA 08/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2010
1	Neurotransmitter Agents (Neurotransmitter)IBA 11/2010
1	Nerve Growth Factors (Neurotrophins)IBA 11/2010
1	Chemokine CCL5IBA 12/2004
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2004
1	Chemokine CXCL10IBA 12/2004
1	Neutralizing AntibodiesIBA 08/2004
1	Interferon-gamma (Interferon, gamma)IBA 03/2002

Therapy/Procedure

2	Palliative Care (Palliative Therapy) 11/2021 - 11/2021
2	Therapeutics 11/2021 - 04/2013
2	Immunotherapy 01/2020 - 03/2004
1	Aftercare (After-Treatment) 10/2014
1	Transplantation 12/2013